Study Evaluating Etanercept in Patients With Rheumatoid Arthritis Who Completed Trial 0881A1-301-EU in Spain

Wyeth

Status: Completed

Conditions: Inflammation; Rheumatoid Arthritis

Treatments: Drug: Etanercept

Study type: Observational

Funder types: Industry

Identifiers

NCT00195364

0881A1-301, 101492

Details and patient eligibility

About

The purpose of this study is to evaluate long-term safety of etanercept in patients with rheumatoid arthritis who successfully have completed open-label safety study 0881A1-301-EU

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• To have completed 0881A1-301-EU study in Spain
• Clinical diagnosis by ACR revised criteria of rheumatoid arthritis.

Exclusion criteria

• Hypersensibility to etanercept or any of its components
• Significant concurrent medical disease